BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

879 related articles for article (PubMed ID: 22013971)

  • 1. OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.
    Roth M; Obaidat A; Hagenbuch B
    Br J Pharmacol; 2012 Mar; 165(5):1260-87. PubMed ID: 22013971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLC Family Transporters.
    Liu X
    Adv Exp Med Biol; 2019; 1141():101-202. PubMed ID: 31571165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of organic anion transporters and organic anion transporter polypeptides and their roles in the liver.
    Li TT; An JX; Xu JY; Tuo BG
    World J Clin Cases; 2019 Dec; 7(23):3915-3933. PubMed ID: 31832394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug uptake systems in liver and kidney.
    van Montfoort JE; Hagenbuch B; Groothuis GM; Koepsell H; Meier PJ; Meijer DK
    Curr Drug Metab; 2003 Jun; 4(3):185-211. PubMed ID: 12769665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease.
    Murray M; Zhou F
    Br J Pharmacol; 2017 Jul; 174(13):1908-1924. PubMed ID: 28299773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion-transporting polypeptides.
    Lee W; Ha JM; Sugiyama Y
    J Biol Chem; 2020 Dec; 295(50):17349-17364. PubMed ID: 33051208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug uptake systems in liver and kidney: a historic perspective.
    Hagenbuch B
    Clin Pharmacol Ther; 2010 Jan; 87(1):39-47. PubMed ID: 19924123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory effects of eighteen front-line antibiotics on the substrate uptake mediated by human Organic anion/cation transporters, Organic anion transporting polypeptides and Oligopeptide transporters in in vitro models.
    Lu X; Chan T; Zhu L; Bao X; Velkov T; Zhou QT; Li J; Chan HK; Zhou F
    Eur J Pharm Sci; 2018 Mar; 115():132-143. PubMed ID: 29307856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties.
    Hagenbuch B; Meier PJ
    Pflugers Arch; 2004 Feb; 447(5):653-65. PubMed ID: 14579113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of SLC22A and SLCO families of drug uptake transporters in the context of cancer treatments.
    Cutler MJ; Choo EF
    Curr Drug Metab; 2011 Oct; 12(8):793-807. PubMed ID: 21787263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression and function of organic anion transporting polypeptides in normal tissues and in cancer.
    Obaidat A; Roth M; Hagenbuch B
    Annu Rev Pharmacol Toxicol; 2012; 52():135-51. PubMed ID: 21854228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy-Modulators of Cellular Entry or Pharmacokinetics?
    Brecht K; Schäfer AM; Meyer Zu Schwabedissen HE
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32806706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney.
    Zaïr ZM; Eloranta JJ; Stieger B; Kullak-Ublick GA
    Pharmacogenomics; 2008 May; 9(5):597-624. PubMed ID: 18466105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and Toxicokinetics Roles of Membrane Transporters at Kidney Level.
    Veiga-Matos J; Remião F; Motales A
    J Pharm Pharm Sci; 2020; 23():333-356. PubMed ID: 32997956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation.
    Nies AT; Schaeffeler E; Schwab M
    Pharmacol Ther; 2022 Oct; 238():108268. PubMed ID: 35995278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
    Bachmakov I; Glaeser H; Fromm MF; König J
    Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SLCO (former SLC21) superfamily of transporters.
    Hagenbuch B; Stieger B
    Mol Aspects Med; 2013; 34(2-3):396-412. PubMed ID: 23506880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of organic ion transporters in drug disposition: an update.
    You G
    Curr Drug Metab; 2004 Feb; 5(1):55-62. PubMed ID: 14965250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effects of five alkaloids on the substrate transport mediated through human organic anion and cation transporters.
    Shams T; Lu X; Zhu L; Zhou F
    Xenobiotica; 2018 Feb; 48(2):197-205. PubMed ID: 28093031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic anion transporting polypeptides of the OATP/SLCO superfamily: identification of new members in nonmammalian species, comparative modeling and a potential transport mode.
    Meier-Abt F; Mokrab Y; Mizuguchi K
    J Membr Biol; 2005 Dec; 208(3):213-27. PubMed ID: 16648940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.